Most people infected with the SARS-CoV-2 virus recover after the acute illness. However, a significant proportion of infected individuals develop long-lasting symptoms with a wide range of ...

In a recent study published in Molecular Psychiatry, researchers review the anti-inflammatory effects of ketamine in the peripheral and central nervous systems. To this end, all relevant articles were ...

The story of Q32 Bio, a company that develops therapeutics for inflammatory and autoimmune diseases, started two decades ago. That's when V. Michael Holers, MD, a University of Colorado School of ...

Dianthus achieved its NASDAQ listing last year via a merger with Magenta Therapeutics. The company is focused on development of a single drug candidate, DNTH-103, which targets the complement system, ...

The newborn's immune system is a highly specialized mechanism that takes months to mature and become capable of effectively responding to pathogens. During this phase, adequate nutritional support, ...

Long COVID has mystified the medical community for years, making it a tough condition to diagnose, let alone treat. However, a growing body of research has found more information on what may be behind ...

A new study suggests treatment-resistant depression may be rooted in the immune system. Trauma, stress biology, and mini-brain models reveal a hidden neuroimmune story.

A new study may have found what’s behind long COVID symptoms. Scientists say a portion of the immune system may stay activated after someone recovers from the virus. Research into what causes long ...